Rationale and Design of the ATHENA-HF Trial
نویسندگان
چکیده
منابع مشابه
Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure.
Although therapy with mineralocorticoid receptor antagonists (MRAs) is recommended for patients with chronic heart failure (HF) with reduced ejection fraction and in post-infarction HF, it has not been studied well in acute HF (AHF) despite being commonly used in this setting. At high doses, MRA therapy in AHF may relieve congestion through its natriuretic properties and mitigate the effects of...
متن کاملDesign and Rationale of the APELOT Trial
Ticagrelor is a direct acting on the P2Y12 receptor blocker, which provides faster and greater platelet inhibition than clopidogrel. However, several studies suggested that in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention (PCI), ticagrelor exhibits initial delay in the onset of antiplatelet action. Unlike ST-segment elevation myocardial infarc...
متن کاملThe MeTeOR Trial: Rationale and Design Features
The MeTeOR Trial: Rationale and Design Features Jeffrey N. Katz, MD, MSc 1 Christine E. Chaisson, MPH 2 Brian Cole, MD, MBA 3 Ali Guermazi, MD 4 David J. Hunter, MBBS, PhD 5 Morgan Jones, MD, MPH 6 Bruce A. Levy, MD 7 Lisa A. Mandl, MD, MPH 8 Scott Martin, MD 1 Robert G. Marx, MD, MSc 8 Clare Safran-Norton, PT, PhD 1 Frank W. Roemer, MD 4, 9 Debra Skoniecki, RNP 1 Daniel H. Solomon, MD, MPH 1 K...
متن کاملa study on the design of bio-ethanol process from date wastes of sistan and baluchistan province
اتانول کاربردهای متنوعی در صنایع لاستیک سازی، رنگسازی، حلالها ومکمل سوخت خودرو دارد. اتانول برخلاف نفت از جمله مواد تجدیدپذیر محسوب می شود که مشکلات زیست محیطی و آلودگی نیز ایجاد نمی کند. استفاده از اتانول به عنوان مکمل سوختخودروها از جمله مهمترین مصارف صنعتی این ماده بشمار می رود. با توجه به این موضوع تحقیق و توسعه در زمینه تولید اتانول با درجه خلوص بالا در سطح جهان، و نه تنها در کشور های پیشر...
Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
OBJECTIVE Heart failure with preserved ejection fraction (HFpEF) is characterized by elevated left atrial pressure during rest and/or exercise. The Reduce LAP-HF (Reduce Elevated Left Atrial Pressure in Patients With Heart Failure) trial will evaluate the safety and performance of the Interatrial Shunt Device (IASD) System II, designed to directly reduce elevated left atrial pressure, in patien...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Heart Failure
سال: 2016
ISSN: 2213-1779
DOI: 10.1016/j.jchf.2016.06.003